purpos
reviewvirusinduc
wheez
infanc
risk
factor
asthma
recent
studi
highlight
role
rhinovirus
caus
acut
ill
possibl
contribut
factor
chronic
asthma
recent
findingsrhinovirus
hrv
long
known
common
caus
common
cold
infant
children
recent
develop
molecular
diagnost
led
discoveri
new
virus
also
provid
data
implic
hrv
import
caus
lower
respiratori
infect
acut
virusinduc
wheez
preschool
children
addit
hrvinduc
wheez
episod
appear
identifi
children
increas
risk
subsequ
develop
childhood
asthma
summarycollect
find
rais
possibl
lri
pathogen
hrv
rsv
could
particip
causat
asthma
especi
children
suboptim
antivir
defens
varieti
experiment
model
clinic
studi
use
identifi
possibl
mechan
relat
infect
ensu
host
respons
could
disturb
normal
lung
immunolog
develop
promot
asthma
defin
relationship
could
lead
new
therapeut
prevent
approach
common
form
childhood
asthma
question
whether
respiratori
infect
virus
caus
asthma
controversi
argu
decad
recent
advent
molecular
viral
diagnost
expand
understand
epidemiolog
respiratori
ill
infanc
improv
detect
rate
known
viru
surprisingli
led
onslaught
discoveri
previous
unrecogn
respiratori
virus
new
diagnost
techniqu
particularli
help
understand
role
human
rhinovirus
hrv
particularli
difficult
grow
tissu
cultur
acut
ill
exacerb
chronic
diseas
asthma
chronic
obstruct
lung
diseas
cystic
fibrosi
addit
recent
clinic
studi
highlight
role
hrv
import
lower
airway
pathogen
infanc
suggest
children
wheez
hrv
may
particularli
high
risk
subsequ
develop
asthma
review
focu
role
hrv
infect
earli
childhood
respiratori
ill
discuss
clinic
evid
mechanist
studi
evalu
potenti
role
hrv
infect
initi
asthma
viral
respiratori
infect
univers
first
year
life
caus
wheez
ill
affect
infant
bronchiol
common
wheez
ill
infanc
caus
number
differ
viral
infect
tabl
interestingli
despit
differ
viral
replic
cycl
clinic
manifest
infect
divers
virus
quit
similar
rsv
hrv
mix
viral
infect
common
caus
ill
rsv
infect
respons
major
case
decemb
april
offset
month
southern
hemispher
hrv
infect
account
case
rest
year
hrv
consid
limit
upper
airway
recogn
import
caus
lower
respiratori
infect
hrv
enteroviru
speci
picornavirada
famili
prototyp
strain
divid
group
b
base
pattern
inhibit
certain
antivir
compound
along
molecular
analysi
partial
genet
sequenc
hrv
serotyp
origin
identifi
growth
tissu
cultur
follow
inhibit
specif
antisera
work
larg
complet
although
nontyp
hrv
occasion
report
recent
partial
complet
genet
sequenc
virus
detect
use
molecular
techniqu
reveal
number
hrv
strain
sever
underestim
fact
evid
grow
third
group
hrv
hrv
c
appear
differ
hrv
group
b
enterovirus
newli
discov
virus
quit
common
compris
hrv
detect
clinic
studi
clinic
manifest
appear
similar
hrv
found
contribut
wheez
ill
infant
children
asthma
frequenc
detect
appear
consist
high
studi
conduct
north
america
europ
asia
australia
hrv
either
alon
combin
virus
import
caus
wheez
ill
yet
also
virus
often
detect
asymptomat
infant
children
observ
divers
sever
hrv
clinic
ill
could
relat
either
host
factor
strain
infect
viru
outstand
question
whether
hrv
strain
inher
virul
thu
like
caus
wheez
ill
certainli
case
respiratori
virus
eg
influenza
larg
number
strain
suggest
also
true
hrv
identifi
virul
strain
molecular
mechan
determin
characterist
import
develop
new
therapeut
strategi
aim
lessen
sever
hrvrelat
ill
hrv
replic
best
rel
cool
temperatur
long
assum
infect
limit
upper
airway
although
lung
parenchyma
core
temperatur
airway
consider
cooler
temperatur
larg
medium
size
airway
ideal
hrv
replic
fact
hrv
demonstr
lower
airway
fluid
cell
experiment
infect
upper
airway
furthermor
consider
clinic
evid
link
hrv
infect
lower
respiratori
infect
children
includ
hospit
pneumonia
recent
yearlong
populationbas
studi
children
year
age
found
hrv
detect
children
hospit
respiratori
symptom
fever
hrvrelat
hospit
rate
especi
high
infant
children
asthma
tabl
ii
find
suggest
possibl
infect
hrv
like
rsv
respiratori
virus
directli
injur
airway
tissu
acut
infect
one
uniqu
featur
hrv
infect
larg
number
serotyp
strain
well
thu
hrv
infect
occur
frequent
young
children
account
signific
morbid
relat
upper
lower
respiratori
ill
cough
wheez
tachypnea
associ
viral
respiratori
ill
close
resembl
exacerb
asthma
older
children
children
recurr
virusinduc
wheez
infanc
go
develop
asthma
progress
suggest
viral
respiratori
infect
might
damag
airway
initi
asthma
figur
also
possibl
relationship
causal
virusinduc
wheez
episod
instead
reveal
preexist
tendenc
asthma
secondari
impair
lung
physiolog
antivir
respons
third
possibl
combin
element
first
two
two
hit
hypothesi
viral
infect
promot
asthma
mainli
predispos
children
understand
hostpathogen
interact
determin
sever
respiratori
ill
longterm
sequela
would
great
help
identifi
atrisk
individu
design
new
effect
treatment
prevent
strategi
risk
factor
bronchiol
viral
lri
includ
young
age
especi
first
month
life
small
lung
size
exposur
tobacco
smoke
lungspecif
factor
preexist
airway
hyperrespons
andor
limit
airflow
also
increas
risk
viral
lri
addit
sever
genet
factor
modifi
risk
rsvinduc
wheez
includ
polymorph
gene
encod
surfact
protein
cytokin
chemokin
although
data
limit
hrv
infect
polymorph
may
influenc
sever
ill
viru
longterm
studi
demonstr
infant
hospit
rsv
bronchiol
increas
risk
develop
asthma
later
childhood
risk
increas
strong
famili
histori
atopi
develop
atop
featur
particularli
occur
earli
childhood
type
virusinduc
wheez
episod
also
appear
influenc
risk
subsequ
asthma
wheez
ill
caus
rsv
parainfluenza
virus
influenza
appear
similar
longterm
prognosi
contrast
case
control
studi
conduct
finland
demonstr
infant
hospit
hrvinduc
wheez
found
particularli
high
risk
subsequ
asthma
relationship
persist
least
late
teen
year
find
corrobor
result
two
birth
cohort
studi
childhood
origin
asthma
coast
studi
highrisk
birth
cohort
studi
famili
least
one
parent
allergi
asthma
enrol
prenat
immun
develop
respiratori
ill
prospect
evalu
use
pcr
technolog
viral
etiolog
identifi
wheez
ill
notabl
moder
sever
hrv
infect
without
wheez
infanc
signific
risk
factor
persist
wheez
age
year
moreov
rv
wheez
ill
first
three
year
life
significantli
associ
develop
asthma
age
year
combin
allerg
sensit
hrvinduc
age
associ
highest
risk
develop
asthma
similarli
highrisk
infant
follow
prospect
australia
kusel
colleagu
prospect
evalu
australian
children
compar
respiratori
ill
first
year
life
respiratori
outcom
age
year
wheez
ill
either
hrv
rsv
associ
asthma
age
year
interestingli
associ
signific
children
earli
onset
age
year
allerg
sensit
studi
highlight
role
virusinduc
wheez
infanc
hrv
particular
determin
risk
subsequ
asthma
children
develop
allerg
sensit
earli
age
also
wheez
hrv
high
risk
develop
asthma
infanc
period
profound
growth
develop
lung
chang
occur
time
maximum
suscept
viral
lri
coincid
rais
number
question
relat
longterm
effect
viral
infect
structur
function
develop
lung
lung
develop
begin
week
gestat
continu
even
birth
basic
lung
architectur
includ
differenti
respiratori
airway
differenti
futur
respiratori
ga
exchang
acinar
unit
larg
complet
week
gestat
postnat
alveoli
multipli
alveolar
process
continu
year
lung
growth
maxim
time
involv
continu
remodel
throughout
childhood
murin
model
gene
delet
overexpress
identifi
key
regulatori
factor
lung
growth
alveolar
epiderm
growth
factor
egf
vascular
endotheli
growth
factor
vegf
transform
growth
plateletderiv
growth
factor
pdgf
happen
lung
develop
care
orchestr
process
disrupt
viral
respiratori
infect
first
viral
infect
damag
airway
structur
via
replic
also
induc
inflammatori
immun
respons
vitro
model
demonstr
hrv
replic
enhanc
epithelium
damag
indic
barrier
function
epitheli
layer
import
compon
antivir
defens
fibroblast
also
quit
suscept
hrv
infect
extens
loss
epitheli
layer
would
provid
viral
particl
access
addit
suscept
tissu
sever
infect
caus
consider
damag
lung
tissu
directli
induc
harm
inflammatori
respons
could
advers
effect
lung
develop
lead
chronic
lung
diseas
like
balanc
effect
antivir
respons
damag
inflamm
influenc
short
longterm
effect
develop
lung
virus
rv
infect
rel
cell
airway
virusinduc
inflammatori
respons
may
drive
forc
airway
symptom
lower
airway
dysfunct
acut
infect
epitheli
edema
shed
togeth
mucu
product
promot
airway
obstruct
wheez
viral
rna
activ
innat
immun
respons
bind
molecul
tolllin
dsrna
depend
protein
kinas
pkr
rigi
mechan
activ
host
antivir
effector
mechan
also
secret
chemokin
recruit
addit
inflammatori
cell
airway
replic
underway
mononuclear
cell
strengthen
antivir
respons
secret
interferon
proinflammatori
cytokin
chemokin
interestingli
experiment
clinic
data
indic
interferon
respons
earli
life
invers
associ
sever
viral
respiratori
ill
exampl
airway
epitheli
cell
cultur
subject
asthma
report
produc
reduc
amount
respons
hrv
support
enhanc
viral
replic
furthermor
clinic
evid
babi
low
ex
vivo
interferon
respons
earli
life
like
frequent
viral
respiratori
ill
includ
associ
wheez
experiment
find
suggest
impair
interferon
respons
could
increas
risk
sever
viral
respiratori
infect
infanc
perhap
promot
longterm
damag
airway
structur
interestingli
reduc
respons
infanc
also
observ
children
atop
featur
could
help
explain
atopi
risk
factor
virusinduc
wheez
progress
asthma
figur
coordin
express
adhes
molecul
secret
chemokin
airway
cell
provid
potent
stimulu
recruit
neutrophil
howev
date
convinc
evid
either
benefici
harm
host
product
neutrophil
activ
damag
airway
releas
potent
secretagogu
elastas
upregul
goblet
cell
secret
mucu
howev
rapid
recruit
cell
airway
suggest
respons
import
host
defens
role
respons
longterm
outcom
determin
hrv
infect
also
indirectli
activ
caus
degranul
eosinophil
lymphocytedepend
mechan
effect
could
contribut
enhanc
risk
virusinduc
wheez
children
allerg
sensit
acut
infect
hrv
viral
infect
induc
synthesi
sever
factor
regul
airway
remodel
alveolar
develop
includ
vegf
amphiregulin
activin
fgf
furthermor
viral
infect
upregul
neurotropin
potenti
caus
remodel
airway
neural
network
possibl
promot
nonspecif
airway
respons
singl
repeat
bout
virusinduc
overexpress
regul
lung
develop
remodel
affect
ultim
lung
structur
function
known
interest
regard
longterm
effect
lung
function
asthma
question
may
best
address
anim
model
recent
two
differ
model
hrv
infect
mous
publish
well
method
serial
passag
mous
epitheli
cell
propag
hrv
patholog
featur
physiolog
abnorm
asthma
appear
first
year
life
period
rapid
growth
develop
observ
rais
possibl
contract
recurr
viral
lri
infanc
could
one
sever
pathway
lead
develop
asthma
especi
children
atop
featur
plausibl
mechan
propos
though
yet
proven
relat
viral
infect
earli
life
epitheli
damag
airway
remodel
intermitt
airway
obstruct
lead
asthma
new
experiment
model
need
answer
question
causal
rel
import
hereditari
versu
environment
lifestylerel
factor
progress
virusinduc
wheez
multifactori
childhood
asthma
result
recent
nonrandom
clinic
trial
palivizumab
suggest
prevent
moder
sever
rsv
infect
infanc
also
reduc
subsequ
asthma
addit
evid
treatment
infant
system
corticosteroid
acut
hrv
wheez
ill
reduc
subsequ
risk
recurr
risk
studi
provid
optim
prevent
earli
treatment
viral
lri
earli
childhood
could
reduc
longterm
morbid
relat
asthma
progress
area
would
advanc
develop
effect
practic
antivir
strategi
hrv
respiratori
virus
atopi
wheez
asthma
viral
respiratori
infect
common
first
year
life
period
rapid
lung
develop
children
atop
featur
tend
reduc
respons
also
associ
increas
suscept
viral
lri
viral
replic
induct
inflamm
lower
airway
period
rapid
develop
could
lead
long
term
chang
airway
structur
fibrosi
abnorm
physiolog
airway
hyperrespons
clinic
asthma
